Medication state at the time of the offense: Medication noncompliance, insight and criminal responsibility

Caroline Titcomb Parrott1, Michelle A Jones2, Stanley L Brodsky3

  • 1Taylor Hardin Secure Medical Facility, Tuscaloosa, AL, USA.

Insights

Mock jurors considered defendants' meta-responsibility, including medication compliance and insight into schizophrenia, but this did not influence verdicts. Jurors struggled to adhere to legal duties when assessing criminal responsibility.

Area of Science:

  • Forensic Psychology
  • Legal Psychology

Background:

  • Assessing criminal responsibility in defendants with schizophrenia is complex.
  • Mock jurors' consideration of defendant meta-responsibility (medication compliance, insight) is not well understood.

Purpose of the Study:

  • To examine mock juror consideration of defendant meta-responsibility in schizophrenia cases.
  • To determine if medication compliance and insight influence verdicts and assessments of criminal responsibility.

Main Methods:

  • Mixed-methods study with 173 participants in 30 mock juries.
  • Randomized controlled trial varying expert testimony on medication compliance and insight.
  • Quantitative analysis (linear mixed-modeling) and qualitative focus groups.

Main Results:

  • Manipulations of compliance, insight, and expert testimony did not predict verdict or meta-responsibility outcomes.
  • Qualitative data revealed jurors strongly considered meta-responsibility.
  • Jurors appeared unable or unwilling to fulfill their duties as triers of fact.

Conclusions:

  • Mock jurors' consideration of meta-responsibility did not align with legal requirements.
  • Challenges exist in mock juror decision-making processes regarding defendants with schizophrenia.
  • Findings have implications for legal professionals, expert witnesses, and future research.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
829
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
266
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
221
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
370
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312